Next Article in Journal
Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918
Next Article in Special Issue
Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death
Previous Article in Journal
Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma
Previous Article in Special Issue
Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma
 
 
Article

Article Versions Notes

Cancers 2024, 16(5), 1024; https://doi.org/10.3390/cancers16051024
Action Date Notes Link
article html file updated 25 June 2025 15:06 CEST Update https://www.mdpi.com/2072-6694/16/5/1024/html
article html file updated 5 March 2024 07:07 CET Update -
article pdf uploaded. 5 March 2024 07:06 CET Updated version of record https://www.mdpi.com/2072-6694/16/5/1024/pdf
article xml uploaded. 5 March 2024 07:06 CET Update https://www.mdpi.com/2072-6694/16/5/1024/xml
article xml file uploaded 5 March 2024 07:06 CET Update -
article html file updated 4 March 2024 10:02 CET Original file -
article supplementary file uploaded. 4 March 2024 10:00 CET - https://www.mdpi.com/2072-6694/16/5/1024#supplementary
article pdf uploaded. 4 March 2024 10:00 CET Updated version of record https://www.mdpi.com/2072-6694/16/5/1024/pdf-vor
article xml uploaded. 4 March 2024 10:00 CET Update -
article xml file uploaded 4 March 2024 10:00 CET Original file -
article pdf uploaded. 29 February 2024 18:12 CET Version of Record https://www.mdpi.com/2072-6694/16/5/1024/pdf-vor
Back to TopTop